I

Ildong Holdings Co Ltd
KRX:000230

Watchlist Manager
Ildong Holdings Co Ltd
KRX:000230
Watchlist
Price: 12 470 KRW 0.24% Market Closed
Market Cap: ₩143.9B

Operating Margin

2.2%
Current
Improving
by 9.2%
vs 3-y average of -7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.2%
=
Operating Income
₩13.3B
/
Revenue
₩615.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.2%
=
Operating Income
₩13.3B
/
Revenue
₩615.5B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Ildong Holdings Co Ltd
KRX:000230
140.5B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.8B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
46th
Based on 2 615 companies
46th percentile
2.2%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Ildong Holdings Co Ltd
Glance View

Market Cap
143.9B KRW
Industry
Pharmaceuticals

Ildong Holdings Co., Ltd. engages in the management of subsidiaries. The company is headquartered in Seoul, Seoul. The Company’s products mainly include general drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, anti-histamines, antipyretics, analgesics, respiratory medications, endocrine medications, psychoneurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials, such as synthesises, probiotics and others. In addition, through its subsidiaries, it engages in the advertising agency, medical equipment distribution, software development, food processing and other businesses.

Ildong Holdings Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
2.2%
=
Operating Income
₩13.3B
/
Revenue
₩615.5B
What is Ildong Holdings Co Ltd's current Operating Margin?

The current Operating Margin for Ildong Holdings Co Ltd is 2.2%, which is above its 3-year median of -7%.

How has Operating Margin changed over time?

Over the last 3 years, Ildong Holdings Co Ltd’s Operating Margin has increased from -14.4% to 2.2%. During this period, it reached a low of -19.9% on Sep 30, 2023 and a high of 9% on Mar 31, 2025.

Back to Top